Merck and Moderna revealed Wednesday that their investigational personalized mRNA cancer vaccine demonstrated efficacy in a substantial phase 3 clinical...
mRNA vaccine
The Food and Drug Administration has cleared mFlusiva, a groundbreaking influenza vaccine developed by Moderna using mRNA technology, marking the...